Fundamentos de la terapia celular para el tratamiento de las enfermedades cardiovasculares: no hay una célula adecuada para todo

Rosamond, 2007, Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 115, e69, 10.1161/CIRCULATIONAHA.106.179918

Juonala, 2006, Young adults with family history of coronary heart disease have increased arterial vulnerability to metabolic risk factors: the Cardiovascular Risk in Young Finns Study, Arterioscl Thromb Vasc Biol, 26, 1376, 10.1161/01.ATV.0000222012.56447.00

Haffner, 2002, Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials, Intl J Clin Pract Suppl, 129, 33

Pearson, 2002, Circulation, 106, 388, 10.1161/01.CIR.0000020190.45892.75

Wyatt, 2006, Overweight and obesity: prevalence, consequences, and causes of a growing public health problem, Am J Med Sci, 331, 166, 10.1097/00000441-200604000-00002

Nissen, 2002, Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound, Am J Med, 112, S27, 10.1016/S0002-9343(02)01087-2

Taylor, 2008, Cardiovascular cell therapy and endogenous repair, Diabetes Obes Metab, 10, 5, 10.1111/j.1463-1326.2008.00937.x

Hill, 2003, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, N Engl J Med, 348, 593, 10.1056/NEJMoa022287

Nelson, 2007, Sex-dependent attenuation of plaque growth after treatment with bone marrow mononuclear cells, Circ Res, 101, 1319, 10.1161/CIRCRESAHA.107.155564

Rauscher, 2003, Aging, progenitor cell exhaustion, and atherosclerosis, Circulation, 108, 457, 10.1161/01.CIR.0000082924.75945.48

Definition of stem cell. En: WebMD. San Clemente: MedicineNet; 2001:1.

Werner, 2005, Circulating endothelial progenitor cells and cardiovascular outcomes, N Engl J Med, 353, 999, 10.1056/NEJMoa043814

Wang, 2000, Marrow stromal cells for cellular cardiomyoplasty: the importance of microenvironment for milieu dependent differentiation, Circulation, 102, 683

Tse, 2006, Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis, Am J Cardiol, 98, 60, 10.1016/j.amjcard.2006.01.056

Tse, 2003, Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation, Lancet, 361, 47, 10.1016/S0140-6736(03)12111-3

Chaitman, 2006, Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions, Circulation, 113, 2462, 10.1161/CIRCULATIONAHA.105.597500

Taylor, 1998, Regenerating functional myocardium: improved performance after skeletal myoblast transplantation, Nat Med, 4, 929, 10.1038/nm0898-929

Zenovich, 2007, Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells, Handb Exp Pharmacol, 180, 117, 10.1007/978-3-540-68976-8_6

Abdel-Latif, 2007, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis, Arch Intern Med, 167, 989, 10.1001/archinte.167.10.989

Hristov, 2006, Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis, J Cell Mol Med, 10, 727, 10.1111/j.1582-4934.2006.tb00432.x

Lipinski, 2007, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials, J Am Coll Cardiol, 50, 1761, 10.1016/j.jacc.2007.07.041

Lunde, 2006, Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction, N Engl J Med, 355, 1199, 10.1056/NEJMoa055706

Bartunek, 2005, Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety, Circulation, 112, I178

Schuleri, 2008, Early improvement in cardiac tissue perfusion due to mesenchymal stem cells, Am J Physiol Heart Circ Physiol, 294, H2002, 10.1152/ajpheart.00762.2007

Anversa, 2002, Myocyte renewal and ventricular remodelling, Nature, 415, 240, 10.1038/415240a

Oh, 2003, Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction, Proc Natl Acad Sci U S A, 100, 12313, 10.1073/pnas.2132126100

Urbanek, 2005, Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure, Proc Natl Acad Sci U S A, 102, 8692, 10.1073/pnas.0500169102

Ott, 2007, The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells, Nat Clin Pract Cardiovasc Med, 4, S27, 10.1038/ncpcardio0771

Smith, 2007, Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens, Circulation, 115, 896, 10.1161/CIRCULATIONAHA.106.655209

Taylor, 2007, Cell therapy for left ventricular remodeling, Curr Heart Fail Rep, 4, 3, 10.1007/s11897-007-0019-0

Chachques, 2004, Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty, Int J Cardiol, 95, S29, 10.1016/S0167-5273(04)90009-5

Menasche, 2008, The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation, Circulation, 117, 1189, 10.1161/CIRCULATIONAHA.107.734103

McCue, 2008, The real estate of myoblast cardiac transplantation: negative remodeling is associated with location, J Heart Lung Transplant, 27, 116, 10.1016/j.healun.2007.10.011

Silva, 2004, Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation, Tex Heart Inst J, 31, 214

Jong, 2003, Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study, Lancet, 361, 1843, 10.1016/S0140-6736(03)13501-5

Schmidt-Lucke, 2005, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair, Circulation, 111, 2981, 10.1161/CIRCULATIONAHA.104.504340

Eschenhagen, 2002, 3D engineered heart tissue for replacement therapy, Basic Res Cardiol, 97, I146

Zimmermann, 2002, Cardiac grafting of engineered heart tissue in syngenic rats, Circulation, 106, I151

Ott, 2008, Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart, Nat Med, 14, 213, 10.1038/nm1684